Filing Details

Accession Number:
0000950142-15-000193
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-29 17:09:23
Reporting Period:
2015-01-27
Filing Date:
2015-01-29
Accepted Time:
2015-01-29 17:09:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513818 Versartis Inc. VSAR Pharmaceutical Preparations (2834) 244106690
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1377952 Y Anthony Sun C/O Aisling Capital
888 Seventh Avenue, 30Th Floor
New York NY 10106
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-27 145,000 $17.25 2,139,568 No 4 P Indirect See FN
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See FN
Footnotes
  1. The reportable securities are owned directly by Aisling Capital III, LP ("Aisling"), and held indirectly by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. Mr. Sun is a member of the investment committee of Aisling. Mr. Sun disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest.